{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T23:48:51Z","timestamp":1774741731975,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930089"],"award-info":[{"award-number":["81930089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230104"],"award-info":[{"award-number":["82230104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304009"],"award-info":[{"award-number":["82304009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203905"],"award-info":[{"award-number":["82203905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2024AFB498"],"award-info":[{"award-number":["2024AFB498"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funding for Scientific Research Projects from Wuhan Municipal Health Commission","award":["WX23A44"],"award-info":[{"award-number":["WX23A44"]}]},{"name":"Wuhan Municipal Natural Science Foundation-Exploratory Program for Key Clinical Research Projects","award":["2024020801020390"],"award-info":[{"award-number":["2024020801020390"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Most chronic skin diseases are classified as immune-mediated disorders, and targeted treatments, such as those blocking the cytokines IL-17, IL-23, IL-4\/13, and the JAK\u2013STAT pathway, have revolutionized therapy. However, a substantial proportion of patients fail to achieve remission and remain refractory to these therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We meta-analyzed heterogeneous cell clusters in different immune-mediated skin diseases to understand the cell states and molecular pathways contributing to pathogenic heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Therefore, we re-analyzed single-cell RNA-sequencing of 166 skin tissues, including 605\u2009030 cells, to build a single-cell atlas of immune-mediated skin diseases. The results were validated using an independent patient cohort and in vitro fibroblast experiments. Samples were categorized into six groups, termed inflammatory phenotypes (IPs), each characterized by distinct variations in inflammatory pathways. These IPs offered new insights into inflammatory abnormalities and shared characteristics across different skin conditions. Disease-relevant cell states, cytokines, and genes were systematically mapped to individual IPs. Furthermore, cell-type abundance, cytokine infiltration, and metabolic heterogeneity were found to modulate shifts among Th1, Th2 and Th17\/Th22 pathways. IPs were dynamic in individuals and could predict treatment response. Among our cohort, patients with unfavorable therapeutic outcomes exhibited distinct inflammatory patterns, characterized by elevated Th2 in psoriasis and elevated Th17\/Th22 in atopic dermatitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This comprehensive atlas and molecular-based stratification of immune-mediated skin diseases provide new insights into the \u2018pan-inflammation\u2019 features of cell states, which could help guide the development of targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/qjmed\/hcaf233","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:05:23Z","timestamp":1759925123000},"page":"134-147","source":"Crossref","is-referenced-by-count":0,"title":["Deconstruction of immune-mediated skin diseases defines six inflammatory subtypes"],"prefix":"10.1093","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9017-9192","authenticated-orcid":false,"given":"Yanhong","family":"Shou","sequence":"first","affiliation":[{"name":"Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-9539","authenticated-orcid":false,"given":"Ronghui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, P. R.","place":["China"]},{"name":"Hubei Province & Key Laboratory of Skin Infection and Immunity , Wuhan No. 1 Hospital, Wuhan, P. R.","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-1198","authenticated-orcid":false,"given":"Zhao-Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8868-5184","authenticated-orcid":false,"given":"Meijie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3331-5538","authenticated-orcid":false,"given":"Xiao-Yong","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"2026032819432762800_hcaf233-B1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","article-title":"Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?","volume":"48","author":"Guttman-Yassky","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"2026032819432762800_hcaf233-B2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"2026032819432762800_hcaf233-B3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"2026032819432762800_hcaf233-B4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamadermatol.2018.3906","article-title":"Reduced itch associated with dupilumab treatment in 4 patients with prurigo nodularis","volume":"155","author":"Mollanazar","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2026032819432762800_hcaf233-B5","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1111\/jdv.15584","article-title":"Dramatic improvement of generalized prurigo nodularis with dupilumab","volume":"33","author":"Calugareanu","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026032819432762800_hcaf233-B6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/jocd.16123","article-title":"Effectiveness and safety of baricitinib in patients with moderate-to-severe refractory alopecia areata in real world: an open-label, single-center study","volume":"23","author":"Bi","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"2026032819432762800_hcaf233-B7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdcr.2022.01.034","article-title":"Resolution of dupilumab-associated alopecia areata with dosage modification","volume":"22","author":"Kulkarni","year":"2022","journal-title":"JAAD Case Rep"},{"key":"2026032819432762800_hcaf233-B8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jdcr.2020.10.010","article-title":"Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab","volume":"6","author":"Gruenstein","year":"2020","journal-title":"JAAD Case Rep"},{"key":"2026032819432762800_hcaf233-B9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2018.05.040","article-title":"Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa\/acne inversa: 3-year results of a phase 3 open-label extension study","volume":"80","author":"Zouboulis","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026032819432762800_hcaf233-B10","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1111\/jdv.17178","article-title":"Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting","volume":"35","author":"Ribero","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026032819432762800_hcaf233-B11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/CCID.S391356","article-title":"Adalimumab, ustekinumab, and secukinumab in the management of hidradenitis suppurativa: a review of the real-life experience","volume":"16","author":"Martora","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026032819432762800_hcaf233-B12","doi-asserted-by":"crossref","first-page":"eabl9165","DOI":"10.1126\/sciimmunol.abl9165","article-title":"Classification of human chronic inflammatory skin disease based on single-cell immune profiling","volume":"7","author":"Liu","year":"2022","journal-title":"Sci Immunol"},{"key":"2026032819432762800_hcaf233-B13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jid.2023.09.283","article-title":"Optimizing single T-Cell transcriptomic discrimination of atopic dermatitis versus psoriasis vulgaris","volume":"144","author":"Taylor","year":"2024","journal-title":"J Invest Dermatol"},{"key":"2026032819432762800_hcaf233-B14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jaci.2020.01.042","article-title":"Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis","volume":"145","author":"He","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026032819432762800_hcaf233-B15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaci.2023.07.005","article-title":"Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab","volume":"153","author":"Ma","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"2026032819432762800_hcaf233-B16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaci.2022.10.034","article-title":"Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa","volume":"151","author":"Sabat","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"2026032819432762800_hcaf233-B17","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41588-023-01445-4","article-title":"Integrated single-cell chromatin and transcriptomic analyses of human scalp identify gene-regulatory programs and critical cell types for hair and skin diseases","volume":"55","author":"Ober-Reynolds","year":"2023","journal-title":"Nat Genet"},{"key":"2026032819432762800_hcaf233-B18","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"2026032819432762800_hcaf233-B19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jid.2016.09.015","article-title":"Shrinking the psoriasis assessment gap: early Gene-Expression profiling accurately predicts response to long-term treatment","volume":"137","author":"Correa da Rosa","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2026032819432762800_hcaf233-B20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026032819432762800_hcaf233-B21","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jaci.2019.01.047","article-title":"Gene expression signatures of circulating human type 1, 2, and 3 innate lymphoid cells","volume":"143","author":"Li","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026032819432762800_hcaf233-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09546634.2023.2183729","article-title":"Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series","volume":"34","author":"Gargiulo","year":"2023","journal-title":"J Dermatolog Treat"},{"key":"2026032819432762800_hcaf233-B23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"2026032819432762800_hcaf233-B24","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1111\/jdv.16097","article-title":"Keloid lesions show increased IL-4\/IL-13 signaling and respond to Th2-targeting dupilumab therapy","volume":"34","author":"Diaz","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026032819432762800_hcaf233-B25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2019.02.002","article-title":"Adventitial stromal cells define group 2 innate lymphoid cell tissue niches","volume":"50","author":"Dahlgren","year":"2019","journal-title":"Immunity"},{"key":"2026032819432762800_hcaf233-B26","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20190689","article-title":"A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissue","volume":"216","author":"Rana","year":"2019","journal-title":"J Exp Med"},{"key":"2026032819432762800_hcaf233-B27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1389200216666150206130058","article-title":"CYP1B1: a unique gene with unique characteristics","volume":"15","author":"Faiq","year":"2014","journal-title":"Curr Drug Metab"},{"key":"2026032819432762800_hcaf233-B28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2741\/4526","article-title":"Alpha-Enolase (ENO1), a potential target in novel immunotherapies","volume":"22","author":"Cappello","year":"2017","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026032819432762800_hcaf233-B29","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jaad.2020.04.182","article-title":"Prurigo nodularis: pathogenesis and management","volume":"83","author":"Williams","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026032819432762800_hcaf233-B30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2012.04481.x","article-title":"Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients","volume":"27","author":"Iking","year":"2013","journal-title":"Acad Dermatol Venereol"},{"key":"2026032819432762800_hcaf233-B31","doi-asserted-by":"crossref","first-page":"02006","DOI":"10.1096\/fasebj.2021.35.S1.02006","article-title":"Inhibition of cytochrome P450 1B1 prevents hepatic stellate cell activation and liver fibrosis","volume":"35","author":"Tung","year":"2021","journal-title":"FASEB J"},{"key":"2026032819432762800_hcaf233-B32","doi-asserted-by":"crossref","first-page":"152791","DOI":"10.1016\/j.imbio.2024.152791","article-title":"Identification and validation of potential biomarkers related to oxidative stress in idiopathic pulmonary fibrosis","volume":"229","author":"Du","year":"2024","journal-title":"Immunobiology"},{"key":"2026032819432762800_hcaf233-B33","doi-asserted-by":"crossref","first-page":"166441","DOI":"10.1016\/j.bbadis.2022.166441","article-title":"Kallistatin\/Serpina3c inhibits cardiac fibrosis after myocardial infarction by regulating glycolysis via Nr4a1 activation","volume":"1868","author":"Ji","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2026032819432762800_hcaf233-B34","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/all.14826","article-title":"Serum sphingosine-1-phosphate is elevated in atopic dermatitis and associated with severity","volume":"76","author":"Sakai","year":"2021","journal-title":"Allergy"},{"key":"2026032819432762800_hcaf233-B35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/bjd\/ljad305","article-title":"Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa","volume":"189","author":"Petrasca","year":"2023","journal-title":"Br J Dermatol"},{"key":"2026032819432762800_hcaf233-B36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bjd\/ljae144","article-title":"Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled clinical trial","volume":"191","author":"Alavi","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026032819432762800_hcaf233-B37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s13238-018-0505-z","article-title":"IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis","volume":"9","author":"Hou","year":"2018","journal-title":"Protein Cell"},{"key":"2026032819432762800_hcaf233-B38","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jaci.2016.02.033","article-title":"IL-1\u03b2 enhances inflammatory TH2 differentiation","volume":"138","author":"Caucheteux","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2026032819432762800_hcaf233-B39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A critical role of the IL-1\u03b2-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J Invest Dermatol"},{"key":"2026032819432762800_hcaf233-B40","doi-asserted-by":"crossref","first-page":"971071","DOI":"10.3389\/fimmu.2022.971071","article-title":"L36G is associated with cutaneous antiviral competence in psoriasis","volume":"13","author":"Lu","year":"2022","journal-title":"Front Immunol"},{"key":"2026032819432762800_hcaf233-B41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ajpath.2013.04.021","article-title":"Inhibition of CCR7\/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis","volume":"183","author":"Bos\u00e8","year":"2013","journal-title":"Am J Pathol"},{"key":"2026032819432762800_hcaf233-B42","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","article-title":"IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression","volume":"182","author":"Sadik","year":"2020","journal-title":"Cell"},{"key":"2026032819432762800_hcaf233-B43","author":"Ngomti","year":"2022"},{"key":"2026032819432762800_hcaf233-B44","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.immuni.2023.06.012","article-title":"An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression","volume":"56","author":"Luo","year":"2023","journal-title":"Immunity"},{"key":"2026032819432762800_hcaf233-B45","doi-asserted-by":"crossref","first-page":"eabq1558","DOI":"10.1126\/sciimmunol.abq1558","article-title":"A T(H)17-intrinsic IL-1\u03b2-STAT5 axis drives steroid resistance in autoimmune neuroinflammation","volume":"9","author":"Miller-Little","year":"2024","journal-title":"Sci Immunol"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcaf233\/64569844\/hcaf233.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/2\/134\/64569844\/hcaf233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/2\/134\/64569844\/hcaf233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T23:43:37Z","timestamp":1774741417000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/119\/2\/134\/8279666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,9]]},"published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcaf233","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,9]]}}}